Skip to main content

Table 4 Comparison of clinical response

From: Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients

   pCR/mRCB pCR
   No Yes No Yes
Clinical Response to AC complete response 5 18 8 15
partial response 36 31 39 28
stable disease 20 2 20 2
progressive disease 2 0 2 0
  1. Clinical response to neoadjuvant AC (doxorubicin/cyclophosphamide) and pCR)/minimal RCB after subsequent neoadjuvant ixabepilone or paclitaxel in the GSE41998 TNBC cohort [26]
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us